CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.240
https://www.valueinhealthjournal.com/article/S1098-3015(23)03370-3/fulltext
Title :
CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03370-3&doi=10.1016/j.jval.2023.09.240
First page :
Section Title :
Open access? :
No
Section Order :
11742